(2000) reported that endogenously derived reactive oxygen species (ROS) enhance ET‐1 production by glomeruli from rats with T1D and that chronic treatment with ROS scavengers markedly suppresses glomerular ET‐1. Here, EDN1 is linked to type 1 diabetes mellitus.